Elevated maternal serum relaxin concentrations throughout pregnancy in singleton gestations after superovulation

Area of Science:

• Reproductive endocrinology
• Maternal-fetal medicine

Background:

• Relaxin is a key hormone in pregnancy maintenance.
• Superovulation protocols are used to enhance fertility.
• The role of superovulation on relaxin levels is not fully understood.

Purpose of the Study:

• To investigate if superovulation leads to elevated maternal relaxin concentrations.
• To determine if these elevated relaxin levels are independent of human chorionic gonadotropin (hCG) secretion patterns.

Main Methods:

• A comparative study of two groups of women with singleton gestations.
• Group 1: nine women conceived after human menopausal gonadotropin (hMG) stimulation (superovulation).
• Group 2: six women conceived without prior stimulation (controls).
• Maternal serum relaxin and hCG levels were measured throughout the second and third trimesters.

Main Results:

• Women who underwent superovulation (hMG) exhibited significantly higher serum relaxin concentrations throughout pregnancy compared to controls.
• Mean relaxin levels were 1.78 ng/mL in the stimulated group versus 0.73 ng/mL in the nonstimulated group.
• No significant difference in human chorionic gonadotropin (hCG) concentrations was observed between the groups.

Conclusions:

• Superovulation significantly elevates maternal serum relaxin levels during the second and third trimesters of singleton pregnancies.
• These elevated relaxin levels are independent of hCG secretion patterns.
• Findings suggest that factors beyond hCG influence luteal relaxin secretion in superovulated pregnancies.